Medical Science News

RSS

Researchers identify an important mediator of thrombosis in CKD patients

Researchers have identified a potential new signaling pathway and enzyme that may help further the understanding of blood clot formation in chronic kidney disease patients and ultimately be targeted for therapeutic purposes.

1 Nov 2021

COVID-19 antibody levels stay more durable in vaccinated people with prior SARS-CoV-2 infection

In what is believed to be one of the largest studies of its kind, Johns Hopkins Medicine researchers have shown that antibody levels against SARS-CoV-2 (the COVID-19 virus) stay more durable — that is, remain higher over an extended period of time — in people who were infected by the virus and then received protection from two doses of messenger RNA (mRNA) vaccine compared with those who only got immunized.

1 Nov 2021

Curcumin, a bioactive component of turmeric, effectively neutralizes SARS-CoV-2 in vitro

The researchers investigated the neutralizing activity of turmeric root extract, curcumin-containing capsules, and pure curcumin against SARS-CoV-2.

1 Nov 2021

Microtubule regulatory protein inhibits early HIV-1 infection, study finds

Northwestern Medicine investigators have discovered that a microtubule regulatory protein inhibits early HIV type 1 (HIV-1) infection, according to findings published in Proceedings of the National Academy of Sciences.

1 Nov 2021

SARS-CoV-2 introduction events in Québec, Canada

Researchers from McGill University have been investigating the number of introduction events in Quebec.

1 Nov 2021

Identification of novel nanobodies to specifically target SARS-CoV-2 replication protein

Researchers have recently identified two nanobodies that show specific binding against a SARS-CoV-2 replication protein.

1 Nov 2021

BNT162b2 mRNA COVID-19 vaccine effectiveness amongst Italian healthcare workers

A new study has been published in Vaccines that evaluated the effectiveness of Cominarty against documented SARS-CoV-2 infection and symptomatic diseases in the medium to long term.

1 Nov 2021

Structural and molecular contributions to understanding antibody recognition of pathogenic viruses

A new review discusses how molecular and structural biology have contributed to our understanding of antibody recognition of HIV-1, SARS-CoV-2, and Zika.

1 Nov 2021

Study finds inhaled microspheres reduce SARS-CoV-2 infective effectiveness

A new study develops an inhaled microfluidic microsphere with a genetically engineered membrane from the ACE2 receptor-overexpressing cells and macrophages.

1 Nov 2021

Factors predicting cognitive symptoms in long COVID

The researchers focused on finding risk factors for long-term symptom occurrence and severity, with special attention to cognitive impairment.

1 Nov 2021

Study suggests increased pediatric COVID-19 hospitalizations related to increased Delta variant incidence

The current study compares the severity of the illness in children infected by the wild-type strain compared with the VOC now prevalent in terms of outcomes in this age group.

1 Nov 2021

Real-life SARS-CoV-2 Delta variant secondary attack rate on naval ship

A case report appeared recently describing the real-life secondary attack rate of the SARS-CoV-2 Delta variant on a single naval ship.

1 Nov 2021

$Non-thermal atmospheric pressure plasma heals bone fractures in animal bone defect models$

Non-thermal atmospheric pressure plasma heals bone fractures in animal bone defect models

Recent technological innovations which have allowed plasma to be generated at room temperature and at ambient atmosphere in what is called non-thermal atmospheric pressure plasma (NTAPP) have given scientists from Japan the opportunity to apply the therapeutic properties of this "fourth state of matter" to bone regeneration.

1 Nov 2021

Areas with higher 1968 influenza pandemic mortality have lower COVID-19 deaths

A new study demonstrates the influence of prior infectious outbreaks in a large population on succeeding pandemic outcomes.

31 Oct 2021

The ability of natural flavonoids to inhibit SARS-CoV-2

A recent systematic review discusses naturally occurring flavonoids as a promising antiviral alternative against SARS-CoV-2.

31 Oct 2021

Researchers explore whether salivary glands infected with SARS-CoV-2 can diminish long-term immunity

University of Utah Health scientists are leading an effort to determine if salivary glands infected with the virus that causes COVID-19 could diminish a person’s long-term immunity to the disease after being immunized or after recovering from the illness.

30 Oct 2021

Moderna vaccine offers substantial protection against delta variant in vaccinated prisoners

When the delta variant of the coronavirus hit the Sierra Conservation Center — a low- to medium-security prison for men in California — residents who had received the Moderna vaccine were well protected against symptomatic infection, according to Stanford-led research.

30 Oct 2021

Two new studies show how to enhance effectiveness of cancer immunotherapy

Two new studies revealed that anti-PD-1 immunotherapy given before surgery was safe and effective for patients with oral-cavity squamous cell carcinoma (OCSCC) and identified potential molecular biomarkers in the blood and tumors of patients that would show how likely it is that someone would respond to immunotherapy.

30 Oct 2021

Alzheimer's disease develops in a very different way than previously thought

For the first time, researchers have used human data to quantify the speed of different processes that lead to Alzheimer's disease and found that it develops in a very different way than previously thought.

30 Oct 2021

New evidence that SARS-CoV-2 virus can infect the inner ear

Many Covid-19 patients have reported symptoms affecting the ears, including hearing loss and tinnitus. Dizziness and balance problems can also occur, suggesting that the SARS-CoV-2 virus may be able to infect the inner ear.

29 Oct 2021

Medical Science News

Researchers identify an important mediator of thrombosis in CKD patients

COVID-19 antibody levels stay more durable in vaccinated people with prior SARS-CoV-2 infection

Curcumin, a bioactive component of turmeric, effectively neutralizes SARS-CoV-2 in vitro

Microtubule regulatory protein inhibits early HIV-1 infection, study finds

SARS-CoV-2 introduction events in Québec, Canada

Identification of novel nanobodies to specifically target SARS-CoV-2 replication protein

BNT162b2 mRNA COVID-19 vaccine effectiveness amongst Italian healthcare workers

Structural and molecular contributions to understanding antibody recognition of pathogenic viruses

Study finds inhaled microspheres reduce SARS-CoV-2 infective effectiveness

Factors predicting cognitive symptoms in long COVID

Study suggests increased pediatric COVID-19 hospitalizations related to increased Delta variant incidence

Real-life SARS-CoV-2 Delta variant secondary attack rate on naval ship

Non-thermal atmospheric pressure plasma heals bone fractures in animal bone defect models

Areas with higher 1968 influenza pandemic mortality have lower COVID-19 deaths

The ability of natural flavonoids to inhibit SARS-CoV-2

Researchers explore whether salivary glands infected with SARS-CoV-2 can diminish long-term immunity

Moderna vaccine offers substantial protection against delta variant in vaccinated prisoners

Two new studies show how to enhance effectiveness of cancer immunotherapy

Alzheimer's disease develops in a very different way than previously thought

New evidence that SARS-CoV-2 virus can infect the inner ear

Obesity, GLP-1s, and metabolic care

Automation in cell-based workflows

Data management challenges in scientific research

Latest News